A man previously imprisoned for 11 years developed unremitting and treatment-resistant monosymptomatic hypochondriacal psychosis following a period in excess of 12 months in solitary confinement. We are unaware of any other reported incidences of this disorder arising in such circumstances.
Get full access to this article
View all access options for this article.
References
1.
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edition revised) (DSM — III-R) Washington DC, APA.
2.
GrassianS. (1983) Psychopathological effects of solitary confinement. Am. J. Psychiat.140, 1450–4.
3.
GrassianS.FriedmanN. (1986) Effects of sensory deprivation in psychiatric seclusion and solitary confinement. Int. J. Law and Psychiat.8, 49–65.
4.
KraepelinE. (1921) Manic Depressive Insanity and Paranoia (translated BarclayR. M.; ed. RobertsonG. M., 1976) Edinburgh, Livingstone; New York, Arno.
5.
MunroA. (1980) Monosymptomatic hypochondriacal psychosis. Br. J. Hosp. Med.24, 34–8.
MunroA. (1991) Phenomenological aspects of monodelusional disorders. Br. J. Psychiat.159 (suppl 14), 62–41.
8.
NitscheP.WilliamsK. (1913) The history of the prison psychoses, Nerrchsand Mental Disease Monograph Series 13. J. Nerv, and Ment. Dis. Pub. Co., New York.
9.
RidingB. E. J.MunroA. (1975) Pimozide in monosymptomatic psychosis. Lanceti, 400.
10.
SuedfeldP.RamirezC.DeatonJ.Baker-BranG. (1982) Reactions and attributes of prisoners in solitary confinement. Crim. Just, and Behav.9, 303–10.
11.
World Health Organisation (1978) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. Geneva, WHO.
